+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Biopharmaceutical Excipients Market Size, Share & Trends Analysis Report by Product (Polyols, Solubilizers & Surfactants/Emulsifiers, Carbohydrates), by Region, and Segment Forecasts, 2020 - 2027

  • ID: 5004001
  • Report
  • February 2020
  • Region: Global
  • 160 pages
  • Grand View Research
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • ABITEC
  • BASF SE
  • Colorcon
  • Evonik Industries AG
  • Indchem International
  • Merck KGaA
  • MORE
The global biopharmaceutical excipients market size is projected to reach USD 3.0 billion by 2027, exhibiting a CAGR of 5.9%. The demand for biopharmaceutical excipients is anticipated to increase given that several biologicals will be expiring over the next few years. Rapidly evolving development and manufacturing of biosimilars are further contributing to the increasing demand for novel biopharmaceutical excipients. Continuous advancements in the pharmaceutical industry, reduced time taken for manufacturing products, and outsourcing also significantly drive the product demand.

The concept of multifunctional or smart excipients has piqued the interest of market participants owing to their enhanced compressibility and drug release ability. Moreover, they have the ability to overcome challenges associated with drug formulation such as complex drug manufacturing processes and high costs associated with incorporating these products in drugs. Maintaining drug stability while reducing overall costs associated with drug development is of utmost importance to achieve large-scale commercial biopharmaceutical manufacturing.

Thus, market players are investing in the development of multifunctional excipient products to sustain intensifying competition in the industry. Various commercial multifunctional/smart excipients include Ludipress (BASF SE), F-MELT (Fuji Chemical Industries Co., Ltd.), Galen IQ 721 (BENEO-Palatinit GmbH), and MCC SANAQ (Pharmatrans-Sanaq AG).

Further key findings from the report suggest:
  • Increasing focus of pharmaceutical players on utilizing recombinant protein and monoclonal antibodies for bio-generic drug development is expected to drive the biopharmaceutical excipients market growth in the coming years
  • Solubilizers and surfactants/emulsifiers accounted for a significant share in 2019 as they help maintain adequate efficacy of preservatives or antimicrobials in drug formulations
  • Polyols are anticipated to exhibit the fastest growth in terms of revenue from 2020 to 2027, as they are gaining significant traction across the latest drug formulations such as chewable tablets and lozenges
  • North America dominated the overall market in terms of revenue whereas Asia Pacific dominated the market in terms of volume in 2019
  • Key industry participants include Roquette Frères, Spectrum Chemical Manufacturing Corp., Merck KGaA, Colorcon, and BASF SE
  • Companies are inclined toward strategic agreements to maintain their market position. For instance, in February 2019, ABITEC (SPI Pharma) entered into a distribution agreement with Indchem International to distribute ABITEC’s functional lipid excipient product line into the personal care, nutrition, and cosmeceutical markets in India

This report will be delivered within 2 business days.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • ABITEC
  • BASF SE
  • Colorcon
  • Evonik Industries AG
  • Indchem International
  • Merck KGaA
  • MORE
Chapter 1 Executive Summary
1.1 Market Snapshot

Chapter 2 Methodology and Scope
2.1 Market Segmentation & Scope
2.1.1 Estimates and Forecast Timeline
2.2 Research Methodology
2.3 Information Procurement
2.3.1 Purchased database:
2.3.2 internal database
2.3.3 Secondary sources:
2.3.4 Primary Research:
2.3.5 Details of Primary Research
2.3.5.1 Data for primary interviews in North America
2.3.5.2 Data for primary interviews in Europe
2.3.5.3 Data for primary interviews in Asia Pacific
2.3.5.4 Data for primary interviews in Latin America
2.3.5.5 Data for primary interviews in MEA
2.4 Information or Data Analysis
2.4.1 Data Analysis Models
2.5 Market Formulation & Validation
2.6 Model Details
2.6.1 Commodity Flow Analysis (Model 1)
2.6.1.1 Approach 1: Commodity Flow Approach
2.6.2 Volume Price Analysis (Model 2)
2.6.2.1 Approach 2: Volume Price Analysis
2.7 List of Secondary Sources
2.8 List of Primary Sources
2.9 Objectives
2.9.1 Objective 1
2.9.2 Objective 2

Chapter 3 Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.1.1 Market driver analysis
3.1.1.1 Chemical and physical instability of biopharmaceuticals is boosting the development of excipients
3.1.1.2 Increase in focus of pharmaceutical players on bio generic market
3.1.1.3 Cost-efficiency and competency of manufacturers
3.1.1.4 Patent expiry of biological actives
3.1.1.5 Rising adoption of multifunctional excipients
3.1.2 Market restraint analysis
3.1.2.1 Challenges in development of excipients for biologics
3.1.2.2 Issues pertaining to supply chain in biopharmaceutical industry
3.2 Penetration & Growth Prospect Mapping for Products, 2018
3.3 Biopharmaceutical Excipients Market-SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.4 Industry Analysis – Porter’s

Chapter 4 Biopharmaceutical Excipients Market Categorization: Product Estimates & Trend Analysis
4.1 Global Biopharmaceutical Excipients Market: Product Movement Analysis, 2019 & 2027
4.2 Solubilizers & Surfactants/Emulsifiers
4.2.1 Global solubilizers & surfactants/emulsifiers market, by revenue 2016 - 2027 (USD Million)
4.2.2 Global solubilizers & surfactants/emulsifiers market, by volume 2016 - 2027 (Tones)
4.2.3 Triglycerides
4.2.3.1 Global triglycerides market, by revenue 2016 - 2027 (USD Million)
4.2.3.2 Global triglycerides market, by volume 2016 - 2027 (Tones)
4.2.4 Esters
4.2.4.1 Global esters market, by revenue 2016 - 2027 (USD Million)
4.2.4.2 Global esters market, by volume by 2016 - 2027 (Tones)
4.2.5 Other solubilizers
4.2.5.1 Global other solubilizers market, by revenue 2016 - 2027 (USD Million)
4.2.5.2 Global other solubilizers market, by volume 2016 - 2027 (Tones)
4.3 Polyols
4.3.1 Global polyols market, by revenue 2016 - 2027 (USD Million)
4.3.2 Global polyols market, by volume 2016 - 2027 (Tones)
4.3.3 Mannitol
4.3.3.1 Global mannitol market, by revenue 2016 - 2027 (USD Million)
4.3.3.2 Global mannitol market, by volume 2016 - 2027 (Tones)
4.3.4 Sorbitol
4.3.4.1 Global sorbitol market, by revenue 2016 - 2027 (USD Million)
4.3.4.2 Global sorbitol market, by volume 2016 - 2027 (Tones)
4.3.5 Other polyols
4.3.5.1 Global other polyols market, by revenue 2016 - 2027 (USD Million)
4.3.5.2 Global other polyols market, by volume 2016 - 2027 (Tones)
4.4 Carbohydrates
4.4.1 Global carbohydrates market, by revenue 2016 - 2027 (USD Million)
4.4.2 Global carbohydrates market, by volume 2016 - 2027 (Tones)
4.4.3 Dextrose
4.4.3.1 Global dextrose market, by revenue 2016 - 2027 (USD Million)
4.4.3.2 Global dextrose market, by volume 2016 - 2027 (Tones)
4.4.4 Sucrose
4.4.4.1 Global sucrose market, by revenue 2016 - 2027 (USD Million)
4.4.4.2 Global sucrose market, by volume 2016 - 2027 (Tones)
4.4.5 Starch
4.4.5.1 Global starch market, by revenue 2016 - 2027 (USD Million)
4.4.5.2 Global starch market, by volume 2016 - 2027 (Tones)
4.4.6 Other carbohydrate excipients
4.4.6.1 Global other carbohydrates market, by revenue 2016 - 2027 (USD Million)
4.4.6.2 Global other carbohydrates market, by volume 2016 - 2027 (Tones)
4.5 Specialty Excipients
4.5.1 Global specialty excipients market, by revenue 2016 - 2027 (USD Million)
4.5.2 Global specialty excipients market, by volume 2016 - 2027 (Tones)

Chapter 5 Biopharmaceutical Excipients Market Categorization: Regional Estimates & Trend Analysis, by Product
5.1 Biopharmaceutical Excipients Market Share by Region, 2019 & 2027
5.2 North America
5.2.1 North America biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.2.2 U.S.
5.2.2.1 U.S. biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.2.3 Canada
5.2.3.1 Canada biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.3 Europe
5.3.1 Europe biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.3.2 Germany
5.3.2.1 Germany biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.3.3 U.K.
5.3.3.1 U.K. biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.4 Asia Pacific
5.4.1 Asia Pacific biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.2 Japan
5.4.2.1 Japan biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.3 China
5.4.3.1 China biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.4 India
5.4.4.1 India biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.5 Malaysia
5.4.5.1 Malaysia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.6 South Korea
5.4.6.1 South Korea biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.7 Philippines
5.4.7.1 Philippines biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.8 New Zealand
5.4.8.1 New Zealand biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.9 Australia
5.4.9.1 Australia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.10 Singapore
5.4.10.1 Singapore biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.4.11 Indonesia
5.4.11.1 Indonesia biopharma excipients market, by revenue 2016 - 2027 (USD Million)
5.5 Latin America
5.5.1 Latin America biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.5.2 Brazil
5.5.2.1 Brazil biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.6 Middle East & Africa (MEA)
5.6.1 Middle East & Africa biopharmaceutical excipients market, 2016 - 2027 (USD Million)
5.6.2 South Africa
5.6.2.1 South Africa biopharmaceutical excipients market, 2016 - 2027 (USD Million)

Chapter 6 Competitive Landscape
6.1 Strategy Framework
6.2 Market Participation Categorization
6.3 Company Profiles
6.3.1 Merck KGaA
6.3.1.1 Company overview
6.3.1.1.1 Merck Millipore
6.3.1.2 Financial performance
6.3.1.3 Product benchmarking
6.3.1.4 Strategic initiatives
6.3.2 Signet Chemical Corporation Pvt. Ltd.
6.3.2.1 Company overview
6.3.2.2 Financial performance
6.3.2.3 Product benchmarking
6.3.2.4 Strategic initiatives
6.3.3 Sigachi Industries Pvt. Ltd.
6.3.3.1 Company overview
6.3.3.2 Financial performance
6.3.3.3 Product benchmarking
6.3.3.4 Strategic initiatives
6.3.4 Associated British Foods
6.3.4.1 Company overview
6.3.4.2 ABITEC
6.3.4.3 Company overview
6.3.4.4 SPI Pharma
6.3.4.5 Company overview
6.3.4.6 Financial performance
6.3.4.7 Financial performance
6.3.4.7.1 Financial performance
6.3.4.8 Product benchmarking
6.3.4.9 Strategic initiatives
6.3.5 Spectrum Chemical Manufacturing Corp.
6.3.5.1 Company overview
6.3.5.2 Financial performance
6.3.5.3 Product benchmarking
6.3.5.4 Strategic initiatives
6.3.6 Roquette Frères
6.3.6.1 Company overview
6.3.6.2 Financial performance
6.3.6.3 Product benchmarking
6.3.6.4 Strategic initiatives
6.3.7 IMCD
6.3.7.1 Company overview
6.3.7.1.1 Indchem International
6.3.7.2 Financial performance
6.3.7.3 Product benchmarking
6.3.7.4 Strategic initiatives
6.3.8 Clariant
6.3.8.1 Company overview
6.3.8.2 Financial performance
6.3.8.3 Product benchmarking
6.3.8.4 Strategic initiatives
6.3.9 DFE Pharma
6.3.9.1 Company overview
6.3.9.2 Product benchmarking
6.3.9.3 Strategic initiatives
6.3.10 Colorcon
6.3.10.1 Company overview
6.3.10.2 Financial performance
6.3.10.3 Product benchmarking
6.3.10.4 Strategic initiatives
6.3.11 J. RETTENMAIER & SÖHNE GmbH + Co KG
6.3.11.1 Company overview
6.3.11.2 JRS PHARMA
6.3.11.3 Company overview
6.3.11.4 Financial performance
6.3.11.5 Product benchmarking
6.3.11.6 Strategic initiatives
6.3.12 BASF SE
6.3.12.1 Company overview
6.3.12.2 Financial performance
6.3.12.3 Product benchmarking
6.3.12.4 Strategic initiatives
6.3.13 Evonik Industries AG
6.3.13.1 Company overview
6.3.13.2 Financial performance
6.3.13.3 Product benchmarking
6.3.13.4 Strategic initiatives

Note: Product cover images may vary from those shown
3 of 3
  • Merck KGaA
  • Merck Millipore
  • Signet Chemical Corporation Pvt. Ltd.
  • Sigachi Industries Pvt. Ltd.
  • Associated British Foods
  • ABITEC
  • SPI Pharma
  • Spectrum Chemical Manufacturing Corp.
  • Roquette Frères
  • IMCD
  • Indchem International
  • Clariant
  • DFE Pharma
  • Colorcon
  • J. RETTENMAIER & SÖHNE GmbH + Co KG
  • JRS PHARMA
  • BASF SE
  • Evonik Industries AG
Note: Product cover images may vary from those shown
Adroll
adroll